These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Glycosylation-dependent binding of pancreatic type I phospholipase A2 to its specific receptor.
    Author: Fujita H, Kawamoto K, Hanasaki K, Arita H.
    Journal: Biochem Biophys Res Commun; 1995 Apr 06; 209(1):293-9. PubMed ID: 7726849.
    Abstract:
    Pancreatic group I phospholipase A2 (PLA2-I) elicits various biological responses via its specific receptor. The PLA2-I binding to its recombinant soluble receptor was considerably reduced after Peptide: N-glycosidase F treatment of the receptor. In cultured bovine smooth muscle cells, treatment with tunicamycin, a N-glycosylation inhibitor, resulted in a decrease in the number of PLA2-I receptor. In addition, the PLA2-I binding was blocked by the addition of a lectin, Wheat germ agglutinin. These results suggest an involvement of N-linked oligosaccharides of the PLA2-I receptor for its ligand recognition.
    [Abstract] [Full Text] [Related] [New Search]